Small US company seeks support of analysts in its battle with Becton Dickinson
This article was originally published in Clinica
Executive Summary
Becton Dickinson is now regarded a "prime takeover target" following its poor performance in the third quarter and predictions of worse to come, according to Michael Mullen, an analyst at Boston, Massachusetts-based SG Cowen Securities. At the same time, it is involved in a dispute with Retractable Technologies, one of the many small companies developing new safety needle technology.